Inventor · disambiguated record
Nenghui Wang
Also filed as: WANG NENGHUI
8 granted patents·10 pending applications·60 citations·filing 2001–2024
84Inventor score
Files withBRISTOL MYERS SQUIBB CO7COOK II JAMES H3MCDONALD IVAR M2ZHEJIANG WENDA PHARMACEUTICAL TECH CO LTD2BRISTOL MEYERS SQUIBB CO1
Top patents by PatentIndex Score
18 records- 0191US7863291B2Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jan 4, 2011·22 cites·14 claims
- 0287US8309577B2Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligandsCOOK II JAMES H·Filed 2009·Granted Nov 13, 2012·10 cites·18 claims
- 0382US6525044B2Succinoylamino carbocycles and heterocycles as inhibitors of a-β protein productionBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Feb 25, 2003·14 cites·18 claims
- 0476US8507516B2Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligandsMCDONALD IVAR M·Filed 2010·Granted Aug 13, 2013·4 cites·3 claims
- 0575US8278320B2Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligandsMCDONALD IVAR M·Filed 2010·Granted Oct 2, 2012·4 cites·14 claims
- 0674US8481555B2Aza-bicyclic amine N-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugsLENTZ KIMBERLEY A·Filed 2011·Granted Jul 9, 2013·6 cites·9 claims
- 0766US2015094309A1Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 0865US2014221377A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 0964US2025333393A1Heterocyclic compound as tyk2 inhibitor, and synthesis and use thereofZHEJIANG WENDA PHARMACEUTICAL TECH CO LTD·Filed 2024·Application pending·0 cites
- 1062US2013131064A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 1159US2016101104A1Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1258US2015342935A1Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1357US2024182429A1Heterocyclic compound as tyk2 pseudokinase domain inhibitor, synthetic method, and useZHEJIANG WENDA PHARMA TECH LTD·Filed 2022·Application pending·0 cites
- 1456US2012035178A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsCOOK II JAMES H·Filed 2011·Application pending·0 cites
- 1556US2012035189A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsCOOK II JAMES H·Filed 2011·Application pending·0 cites
- 1653US7772221B2Diaminopropane derived macrocycles as inhibitors of β amyloid productionBRISTOL MEYERS SQUIBB CO·Filed 2008·Granted Aug 10, 2010·0 cites·13 claims
- 1749US2024376080A1Compound as tyk2/jak1 pseudokinase domain inhibitor, and synthesis and use methodsZHEJIANG WENDA PHARMACEUTICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 1838US10428071B2Carboline derivative serving as bromodomain inhibitorNINGBO WENDA PHARMA TECHNOLOY LTD·Filed 2017·Granted Oct 1, 2019·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Nenghui Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →